| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |